Therapeutic Drug Monitoring of Levetiracetam in Select Populations

Therapeutic Drug Monitoring of Levetiracetam in Select Populations

Purpose: Levetiracetam (LEV) is a broad spectrum antiepileptic drug (AED) that has a more favorable side effect profile compared to older AEDs. Therapeutic drug monitoring (TDM) of LEV is generally unnecessary given its linear and predictable dose-serum concentration relationship, lack of drug-drug...

Full description

Bibliographic Details
Main Authors:	Dael Jarvie, Sherif Hanafy Mahmoud
Format:	Article
Language:	English
Published:	Canadian Society for Pharmaceutical Sciences 2018-08-01
Series:	Journal of Pharmacy & Pharmaceutical Sciences
Online Access:	https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/30081

Similar Items

Levetiracetam Therapeutic Drug Monitoring in a Large Cohort of Korean Epileptic Patients
by: Changhee Ha, et al.
Published: (2021-08-01)

Therapeutic levetiracetam monitoring during pregnancy: “mind the gap”
by: Maya Berlin, et al.
Published: (2019-05-01)

Subcutaneous Levetiracetam Application Sustains Therapeutic Drug Levels
Published: (2021-05-01)

Review: Is levetiracetam different from other antiepileptic drugs? Levetiracetam and its cellular mechanism of action in epilepsy revisited
by: Rainer Surges, et al.
Published: (2008-07-01)

Levetiracetam – a drug that can be used not only in the treatment of epilepsy
by: Bogusława Pietrzak, et al.
Published: (2019-09-01)

Levetiracetam induced drug reaction with eosinophilia and systemic symptom syndrome
by: Waseem Raja Dar, et al.
Published: (2016-01-01)

Advance on synthesis, pharmacokinetics, and pharmacodynamics of the anti-epileptic drug: Levetiracetam
by: Wang Wei
Published: (2020-01-01)

The pharmacokinetics and neuropharmacological action of the new antiepileptic drugs vigabatrin and levetiracetam
by: Tong, Xin
Published: (2007)

Levetiracetam in Partial Seizures
by: J Gordon Millichap
Published: (2002-06-01)

Levetiracetam-induced pancytopenia
by: Talal Alzahrani, et al.
Published: (2015-01-01)

Levetiracetam in the treatment of epilepsy
by: Bassel Abou-Khalil
Published: (2008-06-01)

Levetiracetam induced rhabdomyolysis
by: Anthony C. Torres, et al.
Published: (2021-01-01)

Levetiracetam effectiveness as add-on therapy in Bulgarian patients with drug-resistant epilepsy
by: Ekaterina I. Viteva, et al.
Published: (2021-04-01)

Augmented Renal Clearance in Critical Illness: An Important Consideration in Drug Dosing
by: Sherif Hanafy Mahmoud, et al.
Published: (2017-09-01)

The enzymatic kinetic resolution of selected 2-bromoalkanoic acids and esters, and their use in the synthesis of anti-epileptic drug Levetiracetam
by: Howard, Roger Matthew
Published: (2006)

Clonidine and Levetiracetam for Tics Compared
by: J Gordon Millichap
Published: (2009-06-01)

Levetiracetam in Landau-Kleffner Syndrome
by: J Gordon Millichap
Published: (2003-11-01)

Effect of Levetiracetam on Motor Learning
by: J Gordon Millichap
Published: (2003-01-01)

Clinical Pharmacology and Pharmacokinetics of Levetiracetam
by: Chanin Clark Wright, et al.
Published: (2013-12-01)

Essential tremor responsive to levetiracetam
by: Abdullah Yılgör, et al.
Published: (2012-03-01)

Pharmacokinetics of levetiracetam in neonates with seizures
by: Merhar, Stephanie L., M.D.
Published: (2011)

Antiepileptic Drug of Levetiracetam Decreases Centrotemporal Spike-Associated Activation in Rolandic Epilepsy
by: Qirui Zhang, et al.
Published: (2018-11-01)

Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats
by: Opeyemi Samson Osuntokun, et al.
Published: (2021-01-01)

Levetiracetam for Pediatric Posttraumatic Seizure Prophylaxis
by: Dragos A. Nita, et al.
Published: (2016-07-01)

Efficacy of levetiracetam in treatment of childhood stuttering
by: Mohammadreza Ghazavi, et al.
Published: (2020-01-01)

Facial Dysmorphism: An Unreported Teratogenicity with Levetiracetam
by: Jyotsana Gupta, et al.
Published: (2017-01-01)

Efficacy and Tolerability of Intravenous Levetiracetam in Children
by: Jose eAceves, et al.
Published: (2013-08-01)

Levetiracetam for the Treatment of Refractor Neonatal Seizures
by: Esengül KELEŞ, et al.
Published: (2012-01-01)

Monotherapy for partial epilepsy: focus on levetiracetam
by: Antonio Gambardella, et al.
Published: (2008-03-01)

Levetiracetam as an alternative therapy for Tourette syndrome
by: MA Mart&iacute;nez-Granero, et al.
Published: (2010-05-01)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
by: Jae Wook Cho, et al.
Published: (2014-04-01)

Intravenous levetiracetam in critically ill children
by: Faruk Incecik, et al.
Published: (2016-01-01)

Efficacy of levetiracetam in refractory childhood epilepsy
by: Keon Su Lee, et al.
Published: (2010-04-01)

Levetiracetam use in the critical care setting
by: Jerzy P Szaflarski, et al.
Published: (2013-08-01)

Delayed Recognition of Levetiracetam-induced Pancytopenia
by: Mohammad Ammad Ud Din, et al.
Published: (2021-03-01)

Pediatric Therapeutic Drug Monitoring for Selective Serotonin Reuptake Inhibitors
by: Jeffrey R. Strawn, et al.
Published: (2021-10-01)

Mechanisms Underlying Aggressive Behavior Induced by Antiepileptic Drugs: Focus on Topiramate, Levetiracetam, and Perampanel
by: Cerine C. Hansen, et al.
Published: (2018-01-01)

Therapeutic drug monitoring.
by: Kshirsagar N
Published: (1994-01-01)

Therapeutic Drug Monitoring of Antiepileptic Drugs
by: Geeta Shakya, et al.
Published: (2008-07-01)

Pharmacokinetic Monitoring of Levetiracetam in Portuguese Refractory Epileptic Patients: Effect of Gender, Weight and Concomitant Therapy
by: Rui Silva, et al.
Published: (2020-10-01)